http://rdf.ncbi.nlm.nih.gov/pubchem/patent/IL-250661-A0

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2857e7a1ac956f4e49c13ce00f71f19a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d79362493392629399a529d819cdccd8
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-22
filingDate 2017-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2017-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber IL-250661-A0
titleOfInvention Crystallization process of antecedents of aripiprazole in sustained-release formulations for the treatment of schizophrenia
priorityDate 2014-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60795
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419492710

Total number of triples: 15.